怡达股份(300721) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue decreased by 21.49% to CNY 242,762,607.39 year-on-year, and decreased by 19.85% to CNY 704,571,872.73 for the year-to-date[7] - Net profit attributable to shareholders decreased by 47.93% to CNY 5,936,472.61 year-on-year, and decreased by 71.98% to CNY 9,616,143.96 for the year-to-date[7] - Basic earnings per share decreased by 48.42% to CNY 0.0734 for the current period, and decreased by 72.24% to CNY 0.1189 for the year-to-date[7] - The company's net profit for Q3 2019 was CNY 2.65 million, a significant decline from CNY 7.61 million in Q3 2018[41] - The total profit for Q3 2019 was CNY 5,541,178.04, a decline of 58.6% compared to CNY 13,377,452.21 in the previous year[45] - The company's total revenue for the year-to-date period was CNY 704,571,872.73, down 20% from CNY 879,087,771.92 in the previous year[47] - The total operating costs for the year-to-date period were CNY 700,663,053.17, a decrease of 17.4% compared to CNY 848,181,172.74 in the same period last year[47] - The company's operating revenue for the current period is CNY 436,195,030.51, a decrease from CNY 504,828,060.64 in the previous period[52] - The net profit for the current period is CNY 26,373,968.18, compared to CNY 20,615,106.95 in the previous period, representing an increase of approximately 27.0%[54] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY -19,895,630.58, a decrease of 119.04%[7] - Net cash flow from operating activities was -¥19,895,630.58, a decrease of 119.04% compared to the same period last year, primarily due to increases in accounts receivable, prepaid accounts, and inventory[16] - Total cash inflow from operating activities was 683,110,905.30 CNY, while cash outflow was 703,006,535.88 CNY, resulting in a net cash flow of -19,895,630.58 CNY[57] - Cash inflow from investment activities was 411,252,219.75 CNY, while cash outflow was 749,352,066.51 CNY, leading to a net cash flow of -338,099,846.76 CNY[58] - Cash inflow from financing activities totaled 452,000,000.00 CNY, with cash outflow of 286,729,969.14 CNY, resulting in a net cash flow of 165,270,030.86 CNY[58] Assets and Liabilities - Total assets increased by 14.61% to CNY 1,589,055,908.19 compared to the end of the previous year[7] - Cash and cash equivalents decreased by 58.42% to ¥126,967,385.71 due to reduced operating cash flow and increased investment in financial products[15] - Fixed assets increased by 63.49% to ¥359,457,551.27 as certain projects were completed and transferred from construction in progress[15] - The total current liabilities increased to ¥390,000,000.00 from ¥270,000,000.00, indicating a rise of approximately 44.4%[32] - The company's total liabilities increased to CNY 681.74 million, up from CNY 461.74 million, marking a rise of 47.6%[34] - The total equity attributable to shareholders decreased to CNY 853.47 million from CNY 870.73 million, a decline of 2.0%[34] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 12,158[11] - The largest shareholder, Liu Zhun, holds 21.24% of the shares, amounting to 17,119,608 shares[11] - The company did not conduct any repurchase transactions among the top 10 shareholders during the reporting period[12] - The company repurchased 800,000 shares for employee stock ownership plans, resulting in an 89.45% increase in treasury stock to ¥22,044,670.00[16] Projects and Developments - The company is in the trial production phase for the "Annual Production of 200 Tons of Titanium Silica Molecular Sieve (TS-1) Catalyst Project," which is 100% completed[20] - The "30,000 Cubic Meters Liquid Chemical Storage Project" is 90% completed and currently under construction[21] - The "15,000 tons/year epoxy propylene project" is currently in the installation phase, with 80% of the total project completed[22] - The "2-ethyl anthraquinone (2-tert-pentyl anthraquinone) and tetrabutyl urea project" with an annual production capacity of 2,000 tons has obtained the "Filing Information Registration Form" and is undergoing planning, environmental assessment, and safety assessment approvals[22] Research and Development - The company reported a decrease in research and development expenses to CNY 5.76 million from CNY 6.46 million, a reduction of 10.7% year-over-year[41] - Research and development expenses for Q3 2019 were CNY 5,760,147.75, down 10.8% from CNY 6,457,610.13 in Q3 2018[45] - Research and development expenses for the current period are CNY 15,564,004.32, a decrease from CNY 17,405,589.59 in the previous period[53] Compliance and Governance - The company has no overdue commitments from major shareholders or related parties during the reporting period[25] - There were no violations regarding external guarantees during the reporting period[26] - The company has not reported any significant changes in net profit compared to the same period last year[26] - The third quarter report was not audited[73]